,reactionmeddraversionpt,reactionmeddrapt,reactionoutcome,safetyreportid
0,22.0,Blood bilirubin increased,6,16639263
1,22.0,Aspartate aminotransferase increased,6,16639263
2,22.0,Death,5,16639263
3,22.0,Carbohydrate antigen 15-3 increased,6,16639263
4,22.0,Alanine aminotransferase increased,6,16639263
5,22.0,Blood albumin decreased,6,16639263
0,22.0,Pollakiuria,6,16639297
1,22.0,Ocular hyperaemia,6,16639297
2,22.0,Vitreous floaters,6,16639297
3,22.0,Tinnitus,6,16639297
0,22.0,Product dose omission,6,16639336
1,22.0,Insomnia,6,16639336
2,22.0,Product supply issue,6,16639336
3,22.0,Nocturia,6,16639336
0,22.0,Product use in unapproved indication,6,16639337
1,22.0,Drug effective for unapproved indication,6,16639337
0,22.1,Cardiac failure,1,16639340
1,22.1,Cardiac failure,1,16639340
0,22.0,Mean cell haemoglobin concentration decreased,3,16639359
1,22.0,Blood chloride decreased,3,16639359
2,22.0,Blood test abnormal,3,16639359
3,22.0,Confusional state,3,16639359
4,22.0,Erythema,3,16639359
5,22.0,Haemoglobin decreased,3,16639359
6,22.0,Rash,3,16639359
7,22.0,Panic attack,3,16639359
8,22.0,Skin disorder,3,16639359
9,22.0,Haematocrit decreased,3,16639359
10,22.0,Heart rate increased,3,16639359
11,22.0,Lymphocyte count decreased,3,16639359
12,22.0,Malignant neoplasm progression,3,16639359
13,22.0,Platelet count increased,3,16639359
14,22.0,Pruritus,3,16639359
15,22.0,Fatigue,3,16639359
16,22.0,Hypotension,3,16639359
17,22.0,Hypothyroidism,3,16639359
18,22.0,Malaise,3,16639359
0,22.0,Neutropenia,6,16639364
0,22.0,Dizziness,6,16639405
1,22.0,Repetitive speech,6,16639405
2,22.0,Off label use,6,16639405
3,22.0,Amnesia,6,16639405
0,22.0,Fatigue,6,16639428
1,22.0,Nausea,6,16639428
0,22.0,Ascites,2,16639434
0,22.0,Muscular weakness,6,16639438
0,22.0,Febrile neutropenia,6,16639441
0,22.0,Metastases to bone,6,16639443
1,22.0,Drug ineffective,6,16639443
2,22.0,Product quality issue,6,16639443
3,22.0,Malaise,6,16639443
4,22.0,Back pain,3,16639443
5,22.0,General physical health deterioration,6,16639443
0,22.0,Tongue oedema,6,16639446
1,22.0,Swelling face,6,16639446
2,22.0,Lip swelling,6,16639446
3,22.0,Drug hypersensitivity,1,16639446
0,22.0,Congestive cardiomyopathy,2,16639450
1,22.0,Oedema peripheral,1,16639450
2,22.0,Cough,2,16639450
3,22.0,Fatigue,2,16639450
4,22.0,Cardiac failure chronic,2,16639450
5,22.0,Orthopnoea,2,16639450
6,22.0,Obesity,6,16639450
7,22.0,Dizziness,1,16639450
8,22.0,Dyspnoea,2,16639450
9,22.0,Pulmonary congestion,2,16639450
10,22.0,Spinal pain,6,16639450
11,22.0,Ventricular hypokinesia,2,16639450
12,22.0,Tachypnoea,2,16639450
0,22.0,Osteonecrosis,6,16639452
0,22.0,Bone marrow failure,6,16639482
1,22.0,Fatigue,3,16639482
2,22.0,Contusion,6,16639482
0,22.0,Rectal haemorrhage,6,16639534
1,22.0,Diarrhoea,3,16639534
2,22.0,Off label use,6,16639534
3,22.0,Blood count abnormal,6,16639534
4,22.0,Rash generalised,3,16639534
0,22.0,Syncope,1,16639549
1,22.0,Asphyxia,1,16639549
2,22.0,Hypoaesthesia,1,16639549
3,22.0,Hypersensitivity,1,16639549
0,22.0,Vomiting,1,16639554
1,22.0,Nausea,1,16639554
2,22.0,Breast cancer metastatic,6,16639554
3,22.0,Metastases to bone,6,16639554
4,22.0,Diarrhoea,1,16639554
5,22.0,Fatigue,4,16639554
6,22.0,Malignant neoplasm progression,6,16639554
0,22.0,Disturbance in attention,1,16639555
1,22.0,Aphasia,1,16639555
2,22.0,Diarrhoea,3,16639555
3,22.0,Vomiting,3,16639555
4,22.0,Decreased appetite,3,16639555
5,22.0,Dizziness,1,16639555
6,22.0,Abdominal pain,1,16639555
7,22.0,Somnolence,1,16639555
0,22.0,Gastritis,6,16639566
1,22.0,General physical health deterioration,6,16639566
2,22.0,Death,5,16639566
3,22.0,Inappropriate schedule of product administration,6,16639566
4,22.0,Malaise,6,16639566
5,22.0,Platelet count decreased,6,16639566
0,22.0,Device related infection,6,16639629
0,22.1,Angiosarcoma,6,16639822
1,22.1,Invasive ductal breast carcinoma,5,16639822
2,22.1,Tumour haemorrhage,6,16639822
0,22.0,Intestinal perforation,6,16639878
1,22.0,Abdominal pain,6,16639878
2,22.0,Cardiac failure,6,16639878
3,22.0,Intestinal ischaemia,6,16639878
4,22.0,Diarrhoea,6,16639878
5,22.0,Colitis,6,16639878
6,22.0,Cardiac arrest,6,16639878
0,22.0,Decreased appetite,3,16639897
1,22.0,General physical health deterioration,3,16639897
2,22.0,Vomiting,3,16639897
3,22.0,Constipation,3,16639897
0,22.1,Taste disorder,6,16639901
1,22.1,Feeling abnormal,6,16639901
2,22.1,Decreased appetite,2,16639901
3,22.1,Dysgeusia,6,16639901
4,22.1,Dry mouth,6,16639901
5,22.1,Onychoclasis,6,16639901
0,22.0,Neutropenia,1,16639905
0,22.0,Feeling hot,1,16639926
1,22.0,Erythema,1,16639926
2,22.0,Hyperhidrosis,1,16639926
3,22.0,Vomiting,1,16639926
0,22.0,Tooth abscess,3,16639936
1,22.0,Herpes zoster,6,16639936
0,22.0,Acute kidney injury,2,16639949
1,22.0,Haemolytic anaemia,2,16639949
2,22.0,Thrombotic thrombocytopenic purpura,2,16639949
3,22.0,Haemolytic uraemic syndrome,2,16639949
4,22.0,Infection,6,16639949
0,22.0,Febrile neutropenia,6,16639954
0,22.1,Dermatitis acneiform,1,16639958
1,22.1,Enterocolitis,1,16639958
0,22.0,Nephritis,6,16640083
0,22.0,Dysarthria,2,16640096
1,22.0,Musculoskeletal stiffness,2,16640096
2,22.0,Dysphagia,2,16640096
3,22.0,Withdrawal syndrome,2,16640096
0,22.0,Intestinal ischaemia,6,16640112
1,22.0,Cardiac failure,6,16640112
2,22.0,Colitis,6,16640112
3,22.0,Cardiac arrest,6,16640112
4,22.0,Abdominal pain,6,16640112
5,22.0,Intestinal perforation,6,16640112
6,22.0,Diarrhoea,6,16640112
0,22.0,Off label use,6,16640119
1,22.0,Skin reaction,1,16640119
0,22.1,Platelet count decreased,3,16640121
1,22.1,Decreased appetite,3,16640121
2,22.1,Neutropenia,3,16640121
3,22.1,General physical health deterioration,3,16640121
4,22.1,Asthenia,3,16640121
5,22.1,Anaemia,3,16640121
6,22.1,Weight decreased,3,16640121
7,22.1,Bacterial tracheitis,3,16640121
0,22.0,Arthralgia,1,16640149
1,22.0,Off label use,6,16640149
2,22.0,Alopecia,1,16640149
3,22.0,Hypertension,1,16640149
0,22.0,Malaise,6,16640175
0,22.0,Pericardial effusion,3,16640261
0,22.0,Taste disorder,6,16640355
1,22.0,Dysphonia,6,16640355
2,22.0,Cholelithiasis,6,16640355
3,22.0,Diarrhoea,6,16640355
4,22.0,Back pain,6,16640355
0,22.0,Dizziness,6,16640468
1,22.0,Headache,6,16640468
2,22.0,Death,5,16640468
0,22.0,Pharyngeal fistula,2,16640474
1,22.0,Radiation necrosis,2,16640474
0,22.0,Breast cancer metastatic,4,16640484
0,22.0,Radiation necrosis,2,16640543
1,22.0,Pharyngeal fistula,2,16640543
0,22.0,Ageusia,6,16640594
1,22.0,Pain,6,16640594
2,22.0,Diarrhoea,6,16640594
3,22.0,Bone pain,6,16640594
0,22.0,Impaired healing,2,16640764
1,22.0,Osteonecrosis of jaw,2,16640764
0,22.0,Acute kidney injury,6,16640881
1,22.0,Acute respiratory failure,6,16640881
2,22.0,Cardiogenic shock,6,16640881
3,22.0,Cardiac tamponade,6,16640881
4,22.0,Pericardial effusion malignant,6,16640881
5,22.0,Cardiac failure congestive,6,16640881
0,22.1,Polyneuropathy,6,16640883
1,22.1,Off label use,6,16640883
2,22.1,Cardiovascular disorder,6,16640883
0,22.0,Chronic kidney disease,1,16640900
1,22.0,Nephritis,3,16640900
0,22.1,Metastases to central nervous system,6,16640902
0,22.1,Pneumonitis,6,16640906
1,22.1,Muscular weakness,6,16640906
2,22.1,Fatigue,6,16640906
3,22.1,Stomatitis,6,16640906
4,22.1,Fatigue,6,16640906
5,22.1,Oesophagitis,6,16640906
6,22.1,Muscular weakness,2,16640906
0,22.1,Cerebral haemorrhage,5,16640933
1,22.1,Pyrexia,5,16640933
2,22.1,Chills,5,16640933
0,22.1,Hypotension,6,16640957
1,22.1,Shock,6,16640957
2,22.1,Essential hypertension,6,16640957
3,22.1,Hyperlipidaemia,3,16640957
4,22.1,Acute kidney injury,1,16640957
5,22.1,Hypophagia,1,16640957
6,22.1,Hypovolaemia,6,16640957
7,22.1,Fatigue,2,16640957
8,22.1,Influenza like illness,6,16640957
0,22.0,Chills,1,16640961
1,22.0,Pain,1,16640961
2,22.0,Back pain,1,16640961
3,22.0,Pain in extremity,1,16640961
0,22.0,Encephalopathy,1,16640966
0,22.0,Asthenia,5,16641002
1,22.0,Dysuria,3,16641002
0,22.0,Interstitial lung disease,6,16641003
1,22.0,Pancreatitis acute,3,16641003
2,22.0,Brain oedema,6,16641003
3,22.0,Neurological decompensation,6,16641003
4,22.0,Respiratory failure,6,16641003
0,22.0,Drug ineffective,6,16641020
1,22.0,Neoplasm,6,16641020
0,22.1,Abdominal pain,1,16641081
0,22.1,Death,5,16641132
0,22.0,Facial paralysis,2,16641146
0,22.0,Asthenia,1,16641170
1,22.0,Erythema,2,16641170
2,22.0,Fibula fracture,6,16641170
3,22.0,Tibia fracture,6,16641170
4,22.0,Lower limb fracture,4,16641170
5,22.0,Pain in extremity,1,16641170
6,22.0,Acute kidney injury,3,16641170
7,22.0,Fall,6,16641170
8,22.0,Limb operation,4,16641170
9,22.0,Skin disorder,6,16641170
10,22.0,Stasis dermatitis,2,16641170
11,22.0,Feeling abnormal,1,16641170
12,22.0,Psychomotor skills impaired,1,16641170
13,22.0,Hypokalaemia,1,16641170
14,22.0,Peripheral swelling,6,16641170
0,22.0,Thinking abnormal,2,16641204
1,22.0,Anxiety,2,16641204
2,22.0,Malaise,3,16641204
3,22.0,Speech disorder,2,16641204
4,22.0,Disturbance in attention,2,16641204
0,22.0,Gastroenteritis,1,16641231
1,22.0,Bronchitis,1,16641231
2,22.0,Alopecia,1,16641231
3,22.0,Arthralgia,1,16641231
4,22.0,Rash,1,16641231
5,22.0,Diarrhoea,1,16641231
6,22.0,Dizziness,1,16641231
7,22.0,Dyspnoea,1,16641231
8,22.0,Dyspnoea,1,16641231
9,22.0,Rash,1,16641231
10,22.0,Product use issue,6,16641231
11,22.0,Peripheral sensory neuropathy,3,16641231
12,22.0,Polyneuropathy,1,16641231
13,22.0,Bronchitis,1,16641231
14,22.0,Rash pustular,1,16641231
15,22.0,Nail discolouration,1,16641231
16,22.0,Dysgeusia,1,16641231
17,22.0,Dyspepsia,1,16641231
18,22.0,Chills,1,16641231
19,22.0,Epistaxis,1,16641231
20,22.0,Back pain,1,16641231
21,22.0,Fatigue,3,16641231
22,22.0,Cough,3,16641231
23,22.0,Pain in jaw,3,16641231
24,22.0,Myalgia,3,16641231
25,22.0,Arthralgia,1,16641231
26,22.0,Oedema,1,16641231
27,22.0,Pyrexia,1,16641231
28,22.0,Oedema,1,16641231
29,22.0,Nausea,1,16641231
30,22.0,Headache,1,16641231
31,22.0,Headache,1,16641231
32,22.0,Disturbance in attention,1,16641231
33,22.0,Muscle spasms,1,16641231
34,22.0,Bone pain,1,16641231
0,22.0,Tubulointerstitial nephritis,3,16641237
1,22.0,Glomerulonephritis,3,16641237
0,22.0,Lymphocyte count decreased,6,16641327
1,22.0,Hypertension,6,16641327
0,22.1,Headache,1,16641377
1,22.1,Cellulitis,6,16641377
2,22.1,Back pain,2,16641377
3,22.1,Abdominal pain upper,2,16641377
4,22.1,Diarrhoea,2,16641377
5,22.1,Eye infection,6,16641377
0,22.0,Jaundice,1,16641379
0,22.0,Neutropenia,6,16641429
1,22.0,Diarrhoea,6,16641429
2,22.0,Pulmonary embolism,5,16641429
3,22.0,Febrile neutropenia,6,16641429
4,22.0,Rash,6,16641429
5,22.0,Anaemia,6,16641429
6,22.0,Peripheral sensory neuropathy,6,16641429
7,22.0,Vomiting,6,16641429
8,22.0,Leukopenia,6,16641429
9,22.0,Thrombocytopenia,6,16641429
10,22.0,Decreased appetite,6,16641429
11,22.0,Nausea,6,16641429
12,22.0,Malaise,6,16641429
0,22.0,Loss of consciousness,1,16641469
1,22.0,Fall,1,16641469
2,22.0,Paralysis,1,16641469
0,22.0,Petit mal epilepsy,1,16641473
0,22.0,Death,5,16641485
0,22.0,Fistula of small intestine,6,16641487
0,22.0,Death,5,16641507
0,22.0,Pancytopenia,1,16641519
1,22.0,Anaemia,3,16641519
0,22.0,Neutropenic sepsis,5,16641541
0,22.1,Disease progression,3,16641603
1,22.1,Dyspnoea,3,16641603
0,22.0,Off label use,6,16641609
1,22.0,Malignant neoplasm progression,6,16641609
0,22.0,Hypertensive urgency,6,16641641
0,22.0,Vomiting,6,16641669
1,22.0,Nausea,6,16641669
2,22.0,Mucosal inflammation,6,16641669
3,22.0,Haemoglobin decreased,6,16641669
4,22.0,Diarrhoea,6,16641669
0,22.0,Product dose omission,6,16641680
1,22.0,Blood calcium increased,1,16641680
0,22.0,Death,5,16641688
0,22.0,Wound,6,16641710
0,22.0,Cerebrovascular accident,6,16641714
1,22.0,Cerebral disorder,6,16641714
2,22.0,Fall,6,16641714
0,22.0,Death,5,16641730
0,22.0,Pyrexia,2,16641738
1,22.0,Cerebral haemorrhage,6,16641738
2,22.0,Chills,2,16641738
0,22.0,Surgery,,16641797
0,22.0,Pneumothorax,6,16641804
1,22.0,Haemoptysis,5,16641804
2,22.0,Pneumopericardium,6,16641804
0,22.0,Intentional product use issue,5,16641806
1,22.0,Death,5,16641806
2,22.0,Off label use,5,16641806
0,22.1,Hyponatraemia,1,16641810
1,22.1,Decreased appetite,1,16641810
2,22.1,Congestive cardiomyopathy,1,16641810
3,22.1,Nausea,1,16641810
4,22.1,Vomiting,1,16641810
5,22.1,Urinary tract infection bacterial,1,16641810
6,22.1,Cardiac failure,1,16641810
0,22.0,Malignant neoplasm progression,3,16641814
0,22.0,Rash,2,16641817
0,22.0,Protein urine,6,16641820
1,22.0,Blood lactate dehydrogenase increased,6,16641820
2,22.0,Calcium ionised decreased,6,16641820
3,22.0,Fatigue,6,16641820
4,22.0,Sleep disorder,6,16641820
5,22.0,Diarrhoea,6,16641820
6,22.0,Pain of skin,6,16641820
7,22.0,Eosinophil count decreased,6,16641820
8,22.0,Macule,6,16641820
9,22.0,Acne,6,16641820
10,22.0,Skin infection,6,16641820
0,22.0,Drug ineffective,6,16641823
1,22.0,Death,5,16641823
0,22.0,Death,5,16641835
0,22.1,Death,5,16641859
1,22.1,Stomatitis,6,16641859
2,22.1,Gastrointestinal motility disorder,6,16641859
3,22.1,Fatigue,6,16641859
4,22.1,Sepsis,6,16641859
5,22.1,Hepatic enzyme abnormal,6,16641859
6,22.1,White blood cell count decreased,6,16641859
7,22.1,Diarrhoea,6,16641859
8,22.1,Haematochezia,6,16641859
9,22.1,Pleural effusion,6,16641859
10,22.1,Pneumonia,6,16641859
11,22.1,Peripheral swelling,6,16641859
12,22.1,Nausea,6,16641859
0,22.0,White blood cell count abnormal,6,16641872
0,22.0,Cerebellar embolism,6,16641903
1,22.0,Vertigo,2,16641903
0,22.0,Death,5,16641905
0,22.0,Neoplasm progression,6,16641910
1,22.0,Empyema,1,16641910
2,22.0,Tinnitus,1,16641910
3,22.0,Deafness,1,16641910
0,22.0,Leukopenia,6,16641911
1,22.0,Neutrophil count decreased,1,16641911
2,22.0,Nausea,6,16641911
3,22.0,Myalgia,6,16641911
4,22.0,Night sweats,6,16641911
5,22.0,Chest discomfort,6,16641911
6,22.0,Skin exfoliation,6,16641911
7,22.0,Anxiety,6,16641911
8,22.0,Circumstance or information capable of leading to medication error,6,16641911
9,22.0,Gastrointestinal stoma complication,6,16641911
10,22.0,Stoma site irritation,6,16641911
11,22.0,Vulvovaginal dryness,6,16641911
12,22.0,Dry skin,6,16641911
13,22.0,Back pain,6,16641911
14,22.0,Abdominal discomfort,1,16641911
15,22.0,Tinnitus,6,16641911
16,22.0,Emotional disorder,6,16641911
17,22.0,Blood urea increased,6,16641911
18,22.0,Neutropenia,6,16641911
19,22.0,Abdominal pain,1,16641911
20,22.0,Alopecia,3,16641911
21,22.0,Abdominal pain upper,6,16641911
22,22.0,Sensory disturbance,2,16641911
23,22.0,Bone marrow failure,6,16641911
24,22.0,Skin hypertrophy,6,16641911
25,22.0,Hot flush,3,16641911
26,22.0,Abdominal distension,6,16641911
27,22.0,Breast mass,6,16641911
28,22.0,Neck pain,6,16641911
29,22.0,Musculoskeletal chest pain,1,16641911
30,22.0,Off label use,6,16641911
31,22.0,Stoma site haemorrhage,6,16641911
32,22.0,Fatigue,3,16641911
33,22.0,Ear pain,6,16641911
34,22.0,Gastrointestinal stoma output increased,6,16641911
35,22.0,Joint stiffness,6,16641911
36,22.0,Product use issue,6,16641911
37,22.0,Full blood count decreased,6,16641911
38,22.0,Upper-airway cough syndrome,6,16641911
39,22.0,Anaemia,6,16641911
40,22.0,Neuropathy peripheral,6,16641911
41,22.0,Laboratory test abnormal,6,16641911
42,22.0,Weight increased,6,16641911
43,22.0,Stoma site pain,6,16641911
44,22.0,Alanine aminotransferase increased,6,16641911
45,22.0,Arthralgia,6,16641911
0,22.0,Hepatic failure,6,16641930
1,22.0,Ascites,6,16641930
0,22.0,Death,5,16641953
0,22.0,Toxicity to various agents,6,16641962
0,22.0,Drug interaction,1,16641966
1,22.0,Gamma-glutamyltransferase increased,1,16641966
2,22.0,Anaemia,1,16641966
3,22.0,Neutropenia,1,16641966
0,22.0,Disseminated intravascular coagulation,6,16641999
1,22.0,Febrile neutropenia,1,16641999
2,22.0,Cerebral infarction,3,16641999
3,22.0,Pneumonia aspiration,5,16641999
4,22.0,Interstitial lung disease,3,16641999
0,22.0,Diarrhoea,,16642004
0,22.0,Neoplasm progression,6,16642006
1,22.0,Osteolysis,6,16642006
2,22.0,Paraplegia,6,16642006
0,22.0,Throat tightness,2,16642014
1,22.0,Cough,2,16642014
0,22.0,Nephrolithiasis,1,16642020
1,22.0,Febrile neutropenia,1,16642020
2,22.0,General physical health deterioration,1,16642020
3,22.0,Nausea,1,16642020
4,22.0,Vomiting,1,16642020
0,22.0,Visual acuity reduced,3,16642028
1,22.0,Papilloedema,3,16642028
2,22.0,Optic neuritis,3,16642028
0,22.0,Contusion,6,16642085
0,22.0,Hepatic enzyme increased,6,16642087
1,22.0,Lymphadenopathy,6,16642087
2,22.0,Skin reaction,6,16642087
3,22.0,Granulocyte count decreased,6,16642087
4,22.0,Alopecia,6,16642087
5,22.0,Ejection fraction decreased,6,16642087
6,22.0,Dermatitis,6,16642087
7,22.0,Lipids increased,6,16642087
8,22.0,Lymphadenopathy mediastinal,6,16642087
9,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16642087
10,22.0,Stomatitis,6,16642087
11,22.0,Pulmonary mass,6,16642087
0,22.1,Fluid retention,6,16642104
1,22.1,Nasopharyngitis,6,16642104
2,22.1,Asthenia,6,16642104
3,22.1,Cardiac disorder,6,16642104
4,22.1,Somnolence,6,16642104
5,22.1,Nausea,6,16642104
6,22.1,Underdose,6,16642104
0,22.0,Death,5,16642164
0,22.0,Haemoptysis,3,16642167
1,22.0,Large cell lung cancer,5,16642167
0,22.0,Supraventricular tachycardia,6,16642184
1,22.0,Fatigue,3,16642184
2,22.0,Asthenia,6,16642184
3,22.0,Hypothyroidism,6,16642184
4,22.0,Muscular weakness,3,16642184
0,22.0,Anaemia,1,16642190
1,22.0,Renal tubular necrosis,1,16642190
2,22.0,Chills,6,16642190
3,22.0,Proteinuria,1,16642190
4,22.0,Tubulointerstitial nephritis,1,16642190
5,22.0,Hot flush,6,16642190
6,22.0,Tremor,6,16642190
7,22.0,Sterile pyuria,6,16642190
8,22.0,Pyrexia,6,16642190
9,22.0,Nephropathy toxic,1,16642190
10,22.0,Acute kidney injury,1,16642190
11,22.0,Oliguria,1,16642190
12,22.0,Drug hypersensitivity,6,16642190
13,22.0,Condition aggravated,1,16642190
14,22.0,Thrombocytopenia,1,16642190
0,22.0,Intestinal obstruction,6,16642195
0,22.0,Disease recurrence,1,16642198
1,22.0,General physical health deterioration,6,16642198
2,22.0,Speech disorder,1,16642198
3,22.0,Dysphagia,1,16642198
4,22.0,Dyslipidaemia,6,16642198
5,22.0,Hypertension,6,16642198
6,22.0,Posterior reversible encephalopathy syndrome,1,16642198
7,22.0,Neurotoxicity,1,16642198
8,22.0,Oral discomfort,1,16642198
0,22.0,Progressive multifocal leukoencephalopathy,5,16642202
0,22.0,Intestinal obstruction,6,16642205
0,22.0,Malignant neoplasm progression,6,16642226
1,22.0,Product use in unapproved indication,6,16642226
0,22.0,Death,5,16642321
0,22.0,Dyspnoea,6,16642322
1,22.0,Pneumonitis,2,16642322
2,22.0,Hypoxia,6,16642322
0,22.1,Febrile neutropenia,1,16642327
0,22.0,Death,5,16642335
0,22.0,Death,5,16642337
0,22.0,Sepsis,2,16642437
0,22.0,Erythema,1,16642467
1,22.0,Loss of consciousness,1,16642467
0,22.1,Hypothyroidism,6,16642470
1,22.1,Adrenal insufficiency,2,16642470
2,22.1,Malignant neoplasm progression,6,16642470
3,22.1,Osteonecrosis of jaw,6,16642470
4,22.1,Osteomyelitis,6,16642470
0,22.0,Septic shock,1,16642479
0,22.1,White blood cell count decreased,6,16642492
1,22.1,Neutrophil count decreased,6,16642492
2,22.1,Neoplasm progression,6,16642492
0,22.0,Neoplasm progression,6,16642538
0,22.0,Renal impairment,3,16642552
0,22.0,Neutrophil count decreased,6,16642615
1,22.0,Full blood count decreased,1,16642615
0,22.0,Product use in unapproved indication,6,16642620
1,22.0,Off label use,6,16642620
2,22.0,Neoplasm progression,6,16642620
0,22.0,Pneumonitis,2,16642655
0,22.0,Cerebral infarction,2,16642663
0,22.0,Breast cancer metastatic,5,16642782
1,22.0,Asthenia,5,16642782
2,22.0,Malignant neoplasm progression,5,16642782
3,22.0,Anxiety,5,16642782
4,22.0,Breakthrough pain,5,16642782
5,22.0,Sedation,5,16642782
6,22.0,Insomnia,6,16642782
7,22.0,Disturbance in attention,5,16642782
8,22.0,Constipation,5,16642782
9,22.0,Metastases to bone,5,16642782
10,22.0,General physical health deterioration,5,16642782
11,22.0,Therapeutic response decreased,6,16642782
0,22.1,Blood count abnormal,6,16642814
1,22.1,Malaise,6,16642814
0,22.0,Neoplasm progression,6,16642858
0,22.0,Aphonia,6,16642868
1,22.0,Product use in unapproved indication,6,16642868
2,22.0,Pharyngeal disorder,6,16642868
3,22.0,Pneumonia,3,16642868
4,22.0,Off label use,6,16642868
0,22.1,Product use in unapproved indication,6,16642877
1,22.1,Off label use,6,16642877
0,22.1,Peritoneal disorder,6,16642885
1,22.1,Hydronephrosis,6,16642885
2,22.1,Hyperplasia adrenal,6,16642885
3,22.1,Ascites,6,16642885
4,22.1,Neoplasm progression,6,16642885
5,22.1,Weight decreased,6,16642885
6,22.1,Pleural effusion,6,16642885
7,22.1,Fat tissue increased,6,16642885
0,22.0,Metastases to liver,5,16642887
1,22.0,Nausea,6,16642887
2,22.0,Vomiting,6,16642887
3,22.0,Pancytopenia,6,16642887
4,22.0,Neutropenia,1,16642887
5,22.0,Dehydration,6,16642887
6,22.0,Hypokalaemia,6,16642887
7,22.0,Drug eruption,6,16642887
8,22.0,Breast cancer stage IV,5,16642887
9,22.0,Leukopenia,1,16642887
10,22.0,Malignant neoplasm progression,5,16642887
11,22.0,Metastases to bone,5,16642887
12,22.0,Insomnia,6,16642887
13,22.0,Hyponatraemia,6,16642887
14,22.0,Thrombocytopenia,6,16642887
0,22.0,Febrile neutropenia,6,16642893
1,22.0,Influenza like illness,6,16642893
2,22.0,Off label use,6,16642893
0,22.0,Pain in extremity,1,16642907
1,22.0,Infusion related reaction,1,16642907
0,22.0,Cerebral haemorrhage,1,16642931
0,22.0,Increased tendency to bruise,6,16642944
1,22.0,Fatigue,6,16642944
2,22.0,Bone marrow failure,6,16642944
0,22.0,Asthenia,6,16642968
1,22.0,Lip blister,6,16642968
2,22.0,Lip pain,6,16642968
3,22.0,Rhinorrhoea,6,16642968
0,22.0,Hot flush,6,16643023
0,22.0,Therapy cessation,6,16643024
0,22.0,Depressed mood,3,16643077
1,22.0,Dizziness,6,16643077
2,22.0,Nausea,3,16643077
3,22.0,Diplopia,3,16643077
4,22.0,Fatigue,3,16643077
5,22.0,Blood disorder,2,16643077
0,22.1,Death,5,16643080
1,22.1,Intentional product use issue,6,16643080
0,22.0,Arthritis,6,16643121
1,22.0,Rheumatoid arthritis,6,16643121
0,22.1,Anxiety,6,16643140
0,22.0,Adverse event,6,16643148
0,22.0,Acute kidney injury,5,16643219
0,22.1,Pneumonia,3,16643248
1,22.1,Pulmonary fistula,3,16643248
2,22.1,Pulmonary embolism,3,16643248
0,22.0,Metastases to liver,6,16643252
1,22.0,Neurotoxicity,6,16643252
2,22.0,Therapeutic product effect incomplete,6,16643252
0,22.0,Adverse drug reaction,6,16643276
1,22.0,Carbohydrate antigen 125 increased,3,16643276
2,22.0,Palpitations,1,16643276
3,22.0,Palpitations,6,16643276
4,22.0,Dyspnoea,1,16643276
5,22.0,Fatigue,6,16643276
6,22.0,Dyspnoea,6,16643276
7,22.0,Hip arthroplasty,6,16643276
8,22.0,Weight decreased,2,16643276
9,22.0,Blood test abnormal,6,16643276
10,22.0,Decreased appetite,6,16643276
0,22.1,Ingrown hair,6,16643354
1,22.1,Lymphadenopathy,6,16643354
2,22.1,Influenza,6,16643354
3,22.1,Product dose omission,6,16643354
4,22.1,Rash,6,16643354
5,22.1,Fatigue,6,16643354
6,22.1,White blood cell count decreased,6,16643354
0,22.1,Neoplasm progression,6,16643356
1,22.1,Full blood count decreased,6,16643356
0,22.0,Alopecia,3,16643367
1,22.0,Hair texture abnormal,3,16643367
2,22.0,Hair disorder,3,16643367
3,22.0,Madarosis,3,16643367
4,22.0,Hair colour changes,3,16643367
0,22.0,Hypertension,6,16643440
1,22.0,Blood thyroid stimulating hormone increased,6,16643440
2,22.0,Diarrhoea,6,16643440
3,22.0,Generalised oedema,6,16643440
4,22.0,Renal impairment,6,16643440
5,22.0,Protein urine present,6,16643440
0,22.0,Malignant neoplasm progression,3,16643441
1,22.0,General physical health deterioration,6,16643441
0,22.1,Neoplasm progression,1,16643605
0,22.0,Rash pustular,1,16643671
1,22.0,Blood pressure increased,1,16643671
2,22.0,Pruritus,1,16643671
3,22.0,Erythema,1,16643671
0,22.0,Hepatotoxicity,3,16643719
0,22.1,Product use in unapproved indication,6,16643856
1,22.1,Death,5,16643856
2,22.1,Renal impairment,6,16643856
0,22.0,Drug ineffective,6,16643987
1,22.0,Malignant neoplasm progression,5,16643987
2,22.0,Off label use,6,16643987
0,22.1,Delirium,6,16644030
1,22.1,Pyrexia,6,16644030
2,22.1,Malignant neoplasm progression,6,16644030
3,22.1,Pneumonia,6,16644030
4,22.1,Dyspnoea,6,16644030
5,22.1,Oxygen saturation decreased,6,16644030
6,22.1,Malignant hypertension,6,16644030
7,22.1,Weight decreased,6,16644030
8,22.1,Dyspnoea,6,16644030
9,22.1,Pyrexia,6,16644030
10,22.1,Seizure like phenomena,6,16644030
11,22.1,Pyrexia,6,16644030
12,22.1,Cough,6,16644030
0,22.0,Neoplasm malignant,6,16644071
1,22.0,Off label use,6,16644071
0,22.0,Death,5,16644084
0,22.0,Somnolence,1,16644102
1,22.0,Feeling abnormal,6,16644102
2,22.0,Malaise,1,16644102
3,22.0,Influenza,1,16644102
4,22.0,Cellulitis,1,16644102
0,22.0,Death,5,16644111
1,22.0,Localised infection,6,16644111
0,22.0,Pneumonia,6,16644131
1,22.0,Pneumothorax,3,16644131
0,22.0,Language disorder,3,16644151
1,22.0,Metastases to central nervous system,3,16644151
0,22.0,Nausea,6,16644159
1,22.0,Non-small cell lung cancer,5,16644159
2,22.0,Malignant neoplasm progression,5,16644159
3,22.0,Vomiting,6,16644159
4,22.0,Diarrhoea,6,16644159
0,22.0,Lung infection,5,16644298
0,22.0,Pyrexia,3,16644334
1,22.0,Acute kidney injury,1,16644334
2,22.0,Pain,3,16644334
3,22.0,Blood alkaline phosphatase increased,3,16644334
4,22.0,Muscular weakness,3,16644334
0,22.0,Anaemia,1,16644392
1,22.0,Allergic transfusion reaction,6,16644392
0,22.0,Decreased appetite,1,16644406
1,22.0,Nausea,1,16644406
2,22.0,Hypertension,1,16644406
3,22.0,Neutrophil count decreased,1,16644406
4,22.0,Diarrhoea,1,16644406
5,22.0,Blood alkaline phosphatase increased,1,16644406
6,22.0,Aphonia,1,16644406
7,22.0,Asthenia,1,16644406
8,22.0,Fatigue,1,16644406
9,22.0,Constipation,1,16644406
10,22.0,Epistaxis,1,16644406
11,22.0,Anaemia,2,16644406
12,22.0,Pruritus,1,16644406
0,22.0,Fistula,2,16644431
1,22.0,Ill-defined disorder,1,16644431
0,22.0,Dyspnoea,1,16644432
0,22.0,Metastases to bone,6,16644440
1,22.0,Metastases to spine,6,16644440
0,22.0,Neoplasm progression,6,16644464
0,22.0,Adverse event,3,16644512
1,22.0,Product availability issue,3,16644512
0,22.0,Ischaemic stroke,1,16644538
0,22.1,Palmar-plantar erythrodysaesthesia syndrome,3,16644543
1,22.1,Impaired healing,1,16644543
2,22.1,Quadriplegia,6,16644543
0,22.0,Presyncope,1,16644565
1,22.0,Dizziness,1,16644565
2,22.0,Retinal detachment,4,16644565
3,22.0,Diarrhoea,1,16644565
4,22.0,Constipation,1,16644565
5,22.0,Dyspnoea,1,16644565
6,22.0,Pleural effusion,1,16644565
7,22.0,Weight decreased,1,16644565
8,22.0,Condition aggravated,1,16644565
9,22.0,Fatigue,3,16644565
10,22.0,Nausea,1,16644565
11,22.0,Ejection fraction decreased,1,16644565
12,22.0,Back pain,1,16644565
13,22.0,Alopecia,1,16644565
0,22.1,Skin disorder,4,16644566
1,22.1,Oropharyngeal pain,1,16644566
2,22.1,Fatigue,6,16644566
3,22.1,Blister,6,16644566
4,22.1,Breast inflammation,4,16644566
5,22.1,Breast discharge,3,16644566
6,22.1,Lymphoedema,6,16644566
7,22.1,Breast haemorrhage,4,16644566
8,22.1,Breast pain,4,16644566
9,22.1,Pleural effusion,4,16644566
10,22.1,Inflammatory carcinoma of the breast,4,16644566
11,22.1,Paget^s disease of nipple,6,16644566
12,22.1,Back pain,4,16644566
13,22.1,Vomiting,1,16644566
14,22.1,Pain,6,16644566
15,22.1,Headache,1,16644566
16,22.1,Condition aggravated,6,16644566
17,22.1,Diarrhoea,1,16644566
18,22.1,Anaemia,1,16644566
19,22.1,Nausea,6,16644566
20,22.1,Mastitis,4,16644566
21,22.1,Painful respiration,4,16644566
22,22.1,Pain in extremity,6,16644566
23,22.1,Constipation,1,16644566
0,22.0,Nausea,1,16644569
1,22.0,Vomiting,1,16644569
2,22.0,Sepsis,1,16644569
0,22.0,Pseudocirrhosis,6,16644589
0,22.0,Alopecia,3,16644595
0,22.0,Pain,6,16644596
1,22.0,Anxiety,6,16644596
2,22.0,Emotional distress,6,16644596
3,22.0,Psychological trauma,6,16644596
4,22.0,Alopecia,3,16644596
5,22.0,Impaired quality of life,6,16644596
0,22.1,Alopecia,2,16644604
1,22.1,Anxiety,6,16644604
2,22.1,Emotional distress,6,16644604
3,22.1,Impaired quality of life,6,16644604
4,22.1,Psychological trauma,6,16644604
5,22.1,Pain,6,16644604
0,22.0,Hypoxia,6,16644626
0,22.0,Oral herpes,1,16644631
1,22.0,Arthralgia,1,16644631
2,22.0,Macular hole,6,16644631
3,22.0,Epistaxis,1,16644631
4,22.0,Pruritus,1,16644631
5,22.0,Macular scar,1,16644631
6,22.0,Diarrhoea,1,16644631
7,22.0,Fatigue,1,16644631
8,22.0,Lymphoedema,1,16644631
9,22.0,Balance disorder,1,16644631
10,22.0,Back pain,1,16644631
11,22.0,Tachycardia,1,16644631
12,22.0,Abdominal pain upper,1,16644631
13,22.0,Visual impairment,1,16644631
14,22.0,Muscle spasms,1,16644631
0,22.0,Alopecia,2,16644667
0,22.0,Neuropathy peripheral,2,16644718
1,22.0,Dizziness,6,16644718
2,22.0,White blood cell count decreased,6,16644718
0,22.0,Thrombosis,6,16644747
1,22.0,Death,5,16644747
2,22.0,Stomatitis,6,16644747
0,22.0,Pelvic mass,6,16644751
1,22.0,Dry skin,6,16644751
2,22.0,Neurotoxicity,6,16644751
3,22.0,Adenocarcinoma of colon,6,16644751
4,22.0,Pruritus,6,16644751
5,22.0,Hypomagnesaemia,6,16644751
6,22.0,Constipation,6,16644751
7,22.0,Haematotoxicity,6,16644751
0,22.0,Adverse reaction,3,16644754
1,22.0,Pyoderma gangrenosum,3,16644754
0,22.0,Death,5,16644755
1,22.0,Product dispensing error,6,16644755
2,22.0,Adverse drug reaction,6,16644755
0,22.1,Dysphagia,1,16644779
1,22.1,Feeling abnormal,1,16644779
2,22.1,Regurgitation,1,16644779
3,22.1,Eructation,1,16644779
0,22.0,Alopecia,6,16644787
0,22.1,Fatigue,3,16644789
0,22.0,Nausea,6,16644790
1,22.0,Leprosy,6,16644790
2,22.0,Lethargy,6,16644790
0,22.1,Leukopenia,3,16644795
1,22.1,Aspartate aminotransferase increased,6,16644795
2,22.1,Deep vein thrombosis,1,16644795
3,22.1,Alanine aminotransferase increased,6,16644795
4,22.1,Gamma-glutamyltransferase increased,6,16644795
5,22.1,Red cell distribution width increased,6,16644795
6,22.1,Glomerular filtration rate decreased,6,16644795
0,22.0,Metastases to liver,6,16644809
1,22.0,Lymphadenopathy,6,16644809
2,22.0,Malignant neoplasm progression,6,16644809
3,22.0,Breast cancer metastatic,6,16644809
0,22.1,Anaemia,3,16644810
1,22.1,Back pain,1,16644810
2,22.1,Rectal haemorrhage,1,16644810
3,22.1,Dyspnoea,1,16644810
4,22.1,Chest pain,1,16644810
5,22.1,Upper respiratory tract infection,1,16644810
6,22.1,Mucosal inflammation,1,16644810
7,22.1,Condition aggravated,3,16644810
8,22.1,Nasal dryness,3,16644810
9,22.1,Urinary tract infection,1,16644810
10,22.1,Neutropenia,1,16644810
11,22.1,Diarrhoea,3,16644810
12,22.1,Proteinuria,3,16644810
13,22.1,Musculoskeletal pain,3,16644810
14,22.1,Arthralgia,3,16644810
15,22.1,Abdominal pain,1,16644810
16,22.1,Chills,1,16644810
17,22.1,Sputum discoloured,1,16644810
18,22.1,Fatigue,3,16644810
19,22.1,Eye pain,3,16644810
20,22.1,Thrombocytopenia,1,16644810
21,22.1,Pneumonia,1,16644810
22,22.1,Nausea,3,16644810
23,22.1,Cough,1,16644810
24,22.1,Pyrexia,1,16644810
25,22.1,Headache,1,16644810
0,22.1,Hypertension,2,16644816
1,22.1,Aspartate aminotransferase increased,2,16644816
2,22.1,Neutropenia,2,16644816
3,22.1,Gamma-glutamyltransferase increased,2,16644816
4,22.1,Alanine aminotransferase increased,2,16644816
0,22.0,Dyspnoea,1,16644911
1,22.0,Pruritus,1,16644911
2,22.0,Chest pain,1,16644911
3,22.0,Swollen tongue,1,16644911
4,22.0,Epiglottic oedema,1,16644911
0,22.0,Malignant neoplasm progression,3,16644931
1,22.0,Tumour pseudoprogression,3,16644931
0,22.0,Neoplasm progression,6,16645076
0,22.0,Neoplasm progression,6,16645081
0,22.0,Malignant neoplasm progression,6,16645085
1,22.0,Drug ineffective,6,16645085
0,22.0,Drug interaction,1,16645097
1,22.0,Neutropenia,1,16645097
2,22.0,Leukopenia,1,16645097
3,22.0,Pyrexia,1,16645097
0,22.1,Pain,2,16645112
1,22.1,Dizziness,3,16645112
2,22.1,Infection,2,16645112
3,22.1,Breast cancer,6,16645112
4,22.1,Malignant neoplasm progression,6,16645112
5,22.1,Blood creatinine increased,2,16645112
0,22.0,Drug interaction,6,16645134
1,22.0,Spinal pain,5,16645134
2,22.0,Dizziness,5,16645134
3,22.0,Metastases to bone,5,16645134
4,22.0,Somnolence,5,16645134
0,22.0,Cholecystitis chronic,6,16645135
1,22.0,Polyneuropathy,6,16645135
2,22.0,Proteinuria,6,16645135
3,22.0,Neoplasm recurrence,6,16645135
4,22.0,Pain,6,16645135
0,22.0,Malaise,1,16645183
1,22.0,Loss of consciousness,1,16645183
0,22.1,Drug ineffective,6,16645186
1,22.1,Therapy non-responder,6,16645186
0,22.0,Weight decreased,6,16645323
1,22.0,Decreased appetite,6,16645323
0,22.0,Bladder irritation,3,16645329
1,22.0,Bladder injury,3,16645329
2,22.0,Cystitis noninfective,3,16645329
0,22.0,Neutropenia,6,16645333
0,22.1,Fatigue,4,16645334
1,22.1,Pain in extremity,4,16645334
2,22.1,Feeling hot,4,16645334
0,22.0,Death,5,16645420
0,22.0,Femur fracture,6,16645451
0,22.0,Lung neoplasm malignant,3,16645469
0,22.0,Abdominal pain upper,6,16645506
1,22.0,Metastases to liver,6,16645506
2,22.0,Abdominal distension,6,16645506
0,22.0,Death,5,16645520
0,22.0,Death,5,16645566
1,22.0,Multiple fractures,6,16645566
2,22.0,Fall,6,16645566
0,22.0,Blood lactate dehydrogenase increased,6,16645611
1,22.0,Transaminases increased,3,16645611
0,22.0,Interstitial lung disease,1,16645620
0,22.0,Lichenoid keratosis,3,16645626
0,22.0,Fatigue,1,16645659
1,22.0,Asthenia,1,16645659
2,22.0,Refusal of treatment by patient,6,16645659
3,22.0,Syncope,6,16645659
4,22.0,Malaise,6,16645659
5,22.0,Dehydration,6,16645659
6,22.0,Device malfunction,6,16645659
0,22.0,Kidney infection,1,16645688
1,22.0,Intentional product use issue,6,16645688
0,22.0,Drug ineffective,6,16645689
1,22.0,Anaemia,6,16645689
2,22.0,Adverse drug reaction,6,16645689
0,22.0,Death,5,16645744
1,22.0,Malignant neoplasm progression,6,16645744
0,22.0,Syncope,3,16645747
0,22.0,Dehydration,1,16645960
1,22.0,Leukopenia,1,16645960
0,22.0,Alopecia,3,16646016
1,22.0,Cough,3,16646016
2,22.0,Productive cough,3,16646016
0,22.1,Feeling hot,6,16646017
1,22.1,Fatigue,6,16646017
2,22.1,Pain in extremity,6,16646017
0,22.0,Respiratory failure,5,16646074
1,22.0,Pneumocystis jirovecii pneumonia,5,16646074
0,22.0,Application site pain,2,16646109
1,22.0,Product use in unapproved indication,6,16646109
0,22.1,Intestinal ischaemia,5,16646126
1,22.1,Gastrointestinal haemorrhage,5,16646126
0,22.0,Dementia,3,16646171
0,22.1,Tachycardia,1,16646201
1,22.1,Heart rate increased,6,16646201
2,22.1,Respiratory rate increased,6,16646201
3,22.1,Pneumonia,6,16646201
4,22.1,Localised infection,6,16646201
5,22.1,Dyspnoea,6,16646201
6,22.1,Interstitial lung disease,1,16646201
0,22.0,Dysuria,6,16646231
1,22.0,Mobility decreased,6,16646231
2,22.0,Prostate cancer metastatic,6,16646231
3,22.0,Fall,6,16646231
0,22.0,Malignant neoplasm progression,3,16646240
1,22.0,Drug ineffective,6,16646240
2,22.0,Metastasis,6,16646240
0,22.0,Death,5,16646255
0,22.0,Progressive multifocal leukoencephalopathy,5,16646263
0,22.0,Myasthenia gravis,6,16646298
0,22.0,Myelodysplastic syndrome,3,16646306
1,22.0,Second primary malignancy,3,16646306
0,22.0,Lung neoplasm malignant,6,16646328
0,22.0,Death,5,16646332
0,22.0,Pulmonary embolism,5,16646337
1,22.0,Peripheral swelling,6,16646337
2,22.0,Pyrexia,6,16646337
3,22.0,Fatigue,6,16646337
4,22.0,Dyspnoea,6,16646337
5,22.0,Myalgia,6,16646337
6,22.0,Metastases to bone,6,16646337
0,22.1,Sepsis,5,16646355
1,22.1,Diarrhoea,3,16646355
2,22.1,Colitis,5,16646355
3,22.1,Death,5,16646355
4,22.1,Clostridium difficile colitis,5,16646355
5,22.1,Pulmonary embolism,3,16646355
0,22.0,Stevens-Johnson syndrome,6,16646359
0,22.0,Drug level decreased,6,16646376
1,22.0,Somnolence,5,16646376
2,22.0,Drug interaction,6,16646376
3,22.0,Dizziness,5,16646376
4,22.0,Spinal pain,5,16646376
5,22.0,Metastases to bone,5,16646376
0,22.0,Diarrhoea,1,16646417
1,22.0,Condition aggravated,6,16646417
2,22.0,Stomatitis,1,16646417
0,22.0,Stomatitis,2,16646472
1,22.0,Skin exfoliation,2,16646472
2,22.0,Exfoliative rash,2,16646472
0,22.0,Death,5,16646485
0,22.0,Bone marrow failure,2,16646505
0,22.0,Second primary malignancy,3,16646524
1,22.0,Myelodysplastic syndrome,3,16646524
0,22.0,Metastases to lymph nodes,6,16646546
1,22.0,Metastases to skin,6,16646546
0,22.1,Purulent discharge,6,16646547
1,22.1,Pruritus,6,16646547
2,22.1,Swelling face,6,16646547
3,22.1,Blister,6,16646547
0,22.1,Taste disorder,6,16646549
1,22.1,Rectal haemorrhage,6,16646549
0,22.0,Proctitis ulcerative,2,16646561
1,22.0,Colitis ulcerative,2,16646561
0,22.0,Pneumocystis jirovecii pneumonia,5,16646596
1,22.0,Condition aggravated,5,16646596
2,22.0,Drug ineffective,5,16646596
3,22.0,Pneumonitis,5,16646596
4,22.0,Respiratory disorder,5,16646596
5,22.0,Pyrexia,5,16646596
6,22.0,Dyspnoea,5,16646596
7,22.0,Respiratory failure,5,16646596
0,22.0,Lung disorder,3,16646608
0,22.0,Chest pain,3,16646611
1,22.0,Respiratory distress,3,16646611
2,22.0,Dyspnoea,3,16646611
0,22.0,Dysphagia,1,16646618
1,22.0,Speech disorder,1,16646618
2,22.0,Posterior reversible encephalopathy syndrome,1,16646618
0,22.0,Pulmonary embolism,6,16646627
0,22.0,Stomatitis,1,16646683
1,22.0,Large intestine perforation,5,16646683
2,22.0,Nausea,1,16646683
3,22.0,Face oedema,1,16646683
0,22.0,Pancytopenia,6,16646690
1,22.0,Blood pressure decreased,6,16646690
2,22.0,Septic shock,6,16646690
3,22.0,Disseminated intravascular coagulation,5,16646690
4,22.0,Nutritional condition abnormal,6,16646690
5,22.0,Pneumonia,6,16646690
6,22.0,Multiple organ dysfunction syndrome,5,16646690
7,22.0,Blood phosphorus decreased,1,16646690
8,22.0,Acute respiratory distress syndrome,6,16646690
9,22.0,Atrial fibrillation,1,16646690
0,22.1,Hypothyroidism,6,16646722
1,22.1,Diabetes mellitus,6,16646722
0,22.0,Immune-mediated adverse reaction,6,16646740
1,22.0,Pulmonary granuloma,6,16646740
0,22.0,Rash,3,16646764
1,22.0,Arthritis,3,16646764
0,22.0,Vulvovaginal pruritus,6,16646778
1,22.0,Vulvovaginal pain,6,16646778
2,22.0,Rash pruritic,6,16646778
0,22.0,Skin disorder,6,16646784
1,22.0,Blood glucose increased,1,16646784
2,22.0,Off label use,6,16646784
0,22.0,Pyrexia,3,16646791
1,22.0,Asthenia,3,16646791
2,22.0,Stomatitis,3,16646791
3,22.0,Nail discolouration,3,16646791
4,22.0,Diarrhoea,3,16646791
5,22.0,Tachycardia,3,16646791
0,22.0,Intestinal haemorrhage,1,16646816
1,22.0,Gastritis haemorrhagic,1,16646816
2,22.0,Duodenitis,1,16646816
3,22.0,Diverticulitis,1,16646816
4,22.0,Rectal haemorrhage,1,16646816
5,22.0,Cardiac failure,6,16646816
0,22.0,Gastric haemorrhage,1,16646831
1,22.0,Internal haemorrhage,1,16646831
0,22.0,Intestinal obstruction,2,16646832
0,22.0,Drooling,3,16646843
1,22.0,Foaming at mouth,3,16646843
2,22.0,Wheelchair user,3,16646843
3,22.0,Mobility decreased,3,16646843
4,22.0,Somnolence,3,16646843
0,22.1,Cough,3,16646856
1,22.1,Second primary malignancy,3,16646856
2,22.1,Bladder neoplasm,3,16646856
3,22.1,Myocardial infarction,6,16646856
0,22.1,Hypersensitivity,1,16646881
0,22.0,Product use issue,6,16646882
1,22.0,Hair disorder,1,16646882
0,22.0,Psoriasis,1,16646900
0,22.0,Neoplasm progression,6,16646909
1,22.0,Bone marrow failure,6,16646909
0,22.1,Sinus bradycardia,3,16646979
0,22.1,Myocardial infarction,1,16647037
1,22.1,Mucosal inflammation,1,16647037
2,22.1,Abdominal pain upper,1,16647037
3,22.1,Asthenia,1,16647037
4,22.1,Diarrhoea,1,16647037
5,22.1,Leukopenia,1,16647037
6,22.1,Haemoglobin abnormal,1,16647037
0,22.0,White blood cell count decreased,6,16647077
1,22.0,Femur fracture,6,16647077
2,22.0,Neutrophil count increased,6,16647077
3,22.0,Mean cell volume increased,6,16647077
4,22.0,Gait disturbance,6,16647077
5,22.0,Mean cell haemoglobin increased,6,16647077
6,22.0,Basophil count increased,6,16647077
7,22.0,Red blood cell count decreased,6,16647077
8,22.0,Haematocrit decreased,6,16647077
0,22.1,Meningoencephalitis herpetic,5,16647086
0,22.0,Blood chloride increased,6,16647095
1,22.0,Blood glucose increased,6,16647095
2,22.0,Bone marrow failure,6,16647095
3,22.0,White blood cell count increased,6,16647095
4,22.0,Anaemia,6,16647095
5,22.0,Ataxia,6,16647095
6,22.0,Dysphagia,6,16647095
7,22.0,Hepatitis C,6,16647095
8,22.0,Haemolysis,6,16647095
9,22.0,Blood urea increased,6,16647095
10,22.0,Lymphadenopathy,6,16647095
11,22.0,Chronic lymphocytic leukaemia,6,16647095
12,22.0,Dysarthria,6,16647095
13,22.0,Death,5,16647095
14,22.0,Dysphonia,6,16647095
0,22.0,Pulmonary fibrosis,6,16647127
0,22.0,Vena cava thrombosis,6,16647128
0,22.0,Malignant neoplasm progression,3,16647166
0,22.0,Hypoaesthesia,6,16647173
1,22.0,Neuropathy peripheral,6,16647173
2,22.0,Metastases to bone marrow,6,16647173
3,22.0,Malignant neoplasm progression,6,16647173
0,22.0,Perforation,3,16647198
0,22.0,Tumour perforation,1,16647199
0,22.0,Subacute cutaneous lupus erythematosus,6,16647201
0,22.0,Chronic obstructive pulmonary disease,6,16647210
0,22.0,Interstitial lung disease,2,16647213
0,22.0,Disease progression,,16647276
0,22.0,Alopecia,3,16647277
1,22.0,Back pain,6,16647277
2,22.0,Hair colour changes,3,16647277
3,22.0,Hair disorder,3,16647277
4,22.0,Diarrhoea,6,16647277
5,22.0,Vomiting,6,16647277
6,22.0,Nausea,6,16647277
0,22.0,Alopecia,3,16647279
1,22.0,Hair texture abnormal,3,16647279
2,22.0,Hair colour changes,3,16647279
3,22.0,Madarosis,3,16647279
4,22.0,Hair disorder,3,16647279
0,22.0,Madarosis,3,16647285
1,22.0,Hair colour changes,3,16647285
2,22.0,Hair texture abnormal,3,16647285
3,22.0,Hair disorder,3,16647285
0,22.0,Alopecia,3,16647287
1,22.0,Madarosis,3,16647287
2,22.0,Hair texture abnormal,3,16647287
3,22.0,Hair disorder,3,16647287
4,22.0,Hair colour changes,3,16647287
0,22.1,Liver disorder,1,16647293
1,22.1,Pleural effusion,6,16647293
2,22.1,Decreased appetite,6,16647293
3,22.1,Cognitive disorder,6,16647293
0,22.0,Hair disorder,3,16647314
1,22.0,Hair colour changes,3,16647314
2,22.0,Hair texture abnormal,3,16647314
3,22.0,Madarosis,3,16647314
4,22.0,Alopecia,3,16647314
0,22.0,Alopecia,3,16647321
1,22.0,Madarosis,3,16647321
2,22.0,Hair colour changes,3,16647321
3,22.0,Hair texture abnormal,3,16647321
4,22.0,Hair disorder,3,16647321
0,22.0,Pain in extremity,3,16647335
0,22.1,White blood cell count decreased,1,16647341
1,22.1,Interstitial lung disease,5,16647341
2,22.1,Thrombocytopenia,1,16647341
3,22.1,Anaemia,2,16647341
0,22.1,Myocardial infarction,5,16647351
1,22.1,Aortic dissection,3,16647351
0,22.0,Renal impairment,6,16647379
1,22.0,Arrhythmia,5,16647379
2,22.0,Hyperkalaemia,5,16647379
0,22.0,Ischaemic stroke,1,16647387
1,22.0,Cardiac failure,1,16647387
2,22.0,Left ventricular dysfunction,6,16647387
3,22.0,Systolic dysfunction,1,16647387
4,22.0,Embolic stroke,1,16647387
5,22.0,Cardiac ventricular thrombosis,6,16647387
0,22.0,Insomnia,3,16647390
0,22.0,Malaise,6,16647397
0,22.1,Death,5,16647407
1,22.1,Weight decreased,6,16647407
2,22.1,Eating disorder,3,16647407
3,22.1,Dysgeusia,3,16647407
0,22.0,Vomiting,,16647448
1,22.0,Nausea,,16647448
0,22.1,Dysphagia,6,16647454
1,22.1,Overdose,6,16647454
2,22.1,Somnolence,1,16647454
3,22.1,Death,5,16647454
4,22.1,Ileus,6,16647454
0,22.1,Hypoacusis,1,16647502
0,22.0,Surgery,,16647550
1,22.0,Therapy cessation,,16647550
0,22.1,Product dose omission,6,16647551
1,22.1,Memory impairment,2,16647551
2,22.1,Distractibility,2,16647551
0,22.0,Death,,16647564
0,22.0,Disease progression,,16647583
0,22.0,Disease progression,,16647590
1,22.0,Metastasis,,16647590
0,22.0,Disease progression,,16647600
0,22.0,Thrombosis,,16647605
0,22.0,Hypoacusis,6,16647633
0,22.0,Neoplasm progression,6,16647644
0,22.1,Neoplasm progression,6,16647691
1,22.1,Constipation,6,16647691
0,22.0,Infection,,16647697
0,22.0,Subacute cutaneous lupus erythematosus,6,16647728
0,22.0,Chest pain,,16647734
0,22.0,Chemotherapy,6,16647739
0,22.1,Prescribed underdose,6,16647742
1,22.1,Hepatitis fulminant,4,16647742
2,22.1,Disseminated intravascular coagulation,1,16647742
3,22.1,Hepatic encephalopathy,1,16647742
4,22.1,Off label use,6,16647742
0,22.0,Death,,16647749
0,22.1,Adrenal insufficiency,2,16647787
1,22.1,Pneumonitis,1,16647787
2,22.1,Hypothyroidism,3,16647787
3,22.1,Infusion related reaction,1,16647787
4,22.1,Pneumonia bacterial,5,16647787
5,22.1,Septic shock,6,16647787
0,22.1,Paraesthesia,6,16647794
1,22.1,Nasal congestion,3,16647794
2,22.1,Vomiting,6,16647794
3,22.1,Headache,1,16647794
4,22.1,Fatigue,6,16647794
5,22.1,Dysphonia,3,16647794
6,22.1,Burning sensation,1,16647794
7,22.1,Constipation,3,16647794
8,22.1,Underdose,6,16647794
9,22.1,Nausea,1,16647794
10,22.1,Neuropathy peripheral,2,16647794
11,22.1,Pruritus,2,16647794
12,22.1,Diarrhoea,1,16647794
0,22.1,Pyrexia,1,16647796
1,22.1,Disease progression,6,16647796
2,22.1,Glomerular filtration rate decreased,6,16647796
3,22.1,Feeling abnormal,6,16647796
4,22.1,Back pain,6,16647796
5,22.1,Headache,3,16647796
6,22.1,Blood pressure increased,2,16647796
7,22.1,Dehydration,3,16647796
8,22.1,Upper respiratory tract infection,6,16647796
9,22.1,Chest pain,6,16647796
10,22.1,Dyspepsia,3,16647796
11,22.1,Dizziness,6,16647796
12,22.1,Eructation,6,16647796
13,22.1,Intentional dose omission,6,16647796
14,22.1,Pulmonary oedema,1,16647796
15,22.1,Vitamin B12 decreased,6,16647796
16,22.1,Inflammation,6,16647796
17,22.1,Fatigue,2,16647796
18,22.1,Red blood cell count decreased,6,16647796
19,22.1,Macrocytosis,6,16647796
20,22.1,Renal function test abnormal,6,16647796
21,22.1,Blood creatinine increased,6,16647796
22,22.1,Nausea,1,16647796
23,22.1,Heart rate increased,2,16647796
24,22.1,Insomnia,1,16647796
25,22.1,Constipation,2,16647796
0,22.0,Death,5,16647814
0,22.1,Palmar-plantar erythrodysaesthesia syndrome,6,16647822
1,22.1,Fall,1,16647822
2,22.1,Vision blurred,6,16647822
3,22.1,Rash,6,16647822
4,22.1,Blood pressure increased,2,16647822
5,22.1,Weight decreased,6,16647822
6,22.1,Speech disorder,6,16647822
7,22.1,Platelet count decreased,3,16647822
8,22.1,Hyperhidrosis,6,16647822
9,22.1,White blood cell count decreased,6,16647822
10,22.1,Erythema,6,16647822
11,22.1,Balance disorder,1,16647822
12,22.1,Cerebrovascular accident,2,16647822
13,22.1,Asthenia,6,16647822
14,22.1,Headache,6,16647822
15,22.1,Flatulence,6,16647822
0,22.0,Hospitalisation,,16647823
0,22.0,Anaemia,3,16647864
1,22.0,Malignant neoplasm progression,5,16647864
2,22.0,Off label use,1,16647864
0,22.0,Dental restoration failure,3,16647942
1,22.0,Laryngitis,1,16647942
2,22.0,Erythema,1,16647942
3,22.0,Lacrimation increased,2,16647942
4,22.0,Asthenia,1,16647942
5,22.0,Nail disorder,1,16647942
6,22.0,Nasal dryness,1,16647942
7,22.0,Chest discomfort,1,16647942
8,22.0,Stomatitis,3,16647942
9,22.0,Alopecia,1,16647942
10,22.0,Abdominal pain upper,1,16647942
11,22.0,Abdominal pain,1,16647942
12,22.0,Cellulitis,1,16647942
13,22.0,Nausea,1,16647942
14,22.0,Epistaxis,1,16647942
15,22.0,Paronychia,1,16647942
16,22.0,Skin hyperpigmentation,1,16647942
17,22.0,Palmar-plantar erythrodysaesthesia syndrome,1,16647942
18,22.0,Toothache,1,16647942
19,22.0,Neck pain,3,16647942
20,22.0,Tendonitis,1,16647942
21,22.0,Tooth fracture,3,16647942
22,22.0,Hypertension,1,16647942
23,22.0,Neuropathy peripheral,1,16647942
24,22.0,Myalgia,3,16647942
25,22.0,Dyspnoea,1,16647942
26,22.0,Diarrhoea,1,16647942
27,22.0,Vomiting,1,16647942
0,22.0,Back pain,6,16647982
1,22.0,Cyst,6,16647982
2,22.0,Pain in extremity,6,16647982
0,22.1,Vomiting,1,16648037
1,22.1,Hypocalcaemia,1,16648037
2,22.1,Diarrhoea,1,16648037
3,22.1,Neutropenia,1,16648037
0,22.0,White blood cell count decreased,6,16648125
1,22.0,Paraesthesia,6,16648125
2,22.0,Nausea,6,16648125
3,22.0,Arthralgia,6,16648125
4,22.0,Pain,6,16648125
5,22.0,Decreased appetite,6,16648125
6,22.0,Full blood count decreased,6,16648125
7,22.0,Bone marrow failure,6,16648125
0,22.0,Hair colour changes,3,16648126
1,22.0,Alopecia,3,16648126
2,22.0,Alopecia,1,16648126
3,22.0,Suicidal ideation,6,16648126
4,22.0,Hair disorder,3,16648126
5,22.0,Hair texture abnormal,3,16648126
6,22.0,Madarosis,3,16648126
0,22.1,Urinary tract infection,1,16648143
0,22.0,Chest pain,6,16648158
0,22.0,Death,5,16648172
0,22.0,Death,5,16648175
0,22.0,Anaemia,1,16648184
0,22.0,Lethargy,6,16648192
1,22.0,Febrile neutropenia,1,16648192
2,22.0,Neutropenic sepsis,6,16648192
3,22.0,Chills,6,16648192
0,22.1,Renal impairment,1,16648195
1,22.1,Erythema multiforme,1,16648195
2,22.1,Viral infection,1,16648195
0,22.0,Product use issue,6,16648203
1,22.0,Thrombocytopenia,6,16648203
2,22.0,Anaemia,6,16648203
0,22.0,Acute myeloid leukaemia,3,16648209
0,22.0,Drug resistance,6,16648210
0,22.0,Drug resistance,6,16648218
0,22.0,Drug resistance,6,16648219
0,22.0,Drug resistance,6,16648223
0,22.0,Alopecia,3,16648224
1,22.0,Hair disorder,3,16648224
2,22.0,Madarosis,3,16648224
3,22.0,Hair texture abnormal,3,16648224
4,22.0,Hair colour changes,3,16648224
0,22.0,Malaise,6,16648231
1,22.0,Fatigue,6,16648231
2,22.0,Alopecia,6,16648231
0,22.1,Malaise,6,16648241
0,22.0,Pneumonia,6,16648243
1,22.0,Malignant neoplasm progression,6,16648243
2,22.0,Renal cancer,6,16648243
0,22.0,Haematemesis,6,16648283
1,22.0,Haemoptysis,6,16648283
2,22.0,Aspiration,6,16648283
3,22.0,Fall,6,16648283
4,22.0,Fatigue,6,16648283
5,22.0,Sinusitis,6,16648283
6,22.0,Appetite disorder,2,16648283
7,22.0,Dyspnoea,2,16648283
8,22.0,Hypoxia,5,16648283
9,22.0,Cardio-respiratory arrest,5,16648283
10,22.0,Cough,2,16648283
0,22.1,Back pain,3,16648288
1,22.1,Dehydration,1,16648288
2,22.1,Neutropenia,1,16648288
3,22.1,Erysipelas,1,16648288
4,22.1,Liver disorder,6,16648288
5,22.1,Hypocalcaemia,3,16648288
6,22.1,Erythema,6,16648288
7,22.1,Thrombosis,6,16648288
8,22.1,Nausea,1,16648288
9,22.1,Neutropenia,1,16648288
0,22.0,Drug resistance,6,16648297
0,22.0,Drug resistance,6,16648298
0,22.0,Drug resistance,6,16648299
0,22.0,Drug resistance,6,16648300
0,22.0,Peripheral swelling,2,16648321
0,22.0,Dizziness,3,16648325
1,22.0,Dysphonia,,16648325
2,22.0,Fall,,16648325
3,22.0,Dizziness,,16648325
4,22.0,Slow speech,,16648325
5,22.0,Palmar-plantar erythrodysaesthesia syndrome,2,16648325
6,22.0,Weight decreased,,16648325
7,22.0,Paraesthesia oral,3,16648325
8,22.0,Tremor,,16648325
9,22.0,Transient ischaemic attack,,16648325
10,22.0,Fatigue,3,16648325
11,22.0,Colorectal cancer,,16648325
12,22.0,Gait disturbance,,16648325
13,22.0,Change of bowel habit,,16648325
14,22.0,Cerebral infarction,,16648325
15,22.0,Post-traumatic pain,,16648325
16,22.0,Vision blurred,,16648325
0,22.0,Drug resistance,6,16648348
0,22.0,Drug resistance,6,16648355
0,22.0,Cough,1,16648357
1,22.0,Lung disorder,6,16648357
2,22.0,Thyroid disorder,6,16648357
3,22.0,Traumatic lung injury,6,16648357
4,22.0,Interstitial lung disease,6,16648357
0,22.1,Transient ischaemic attack,1,16648384
0,22.0,Drug resistance,6,16648471
0,22.0,Death,5,16648478
1,22.0,Pneumonitis,6,16648478
0,22.0,Myocardial infarction,1,16648539
1,22.0,Diabetes mellitus,3,16648539
2,22.0,Hypertriglyceridaemia,3,16648539
0,22.0,Sepsis,6,16648698
1,22.0,Nausea,6,16648698
2,22.0,Vomiting,6,16648698
3,22.0,Acute respiratory distress syndrome,5,16648698
4,22.0,Dehydration,6,16648698
5,22.0,Enterocolitis infectious,6,16648698
6,22.0,Encephalopathy,6,16648698
7,22.0,Diarrhoea,3,16648698
0,22.0,Pneumonitis,5,16648710
0,22.0,Anaemia,6,16648711
0,22.0,Adverse drug reaction,6,16648748
0,22.0,Thyroiditis,1,16648755
1,22.0,Drug-induced liver injury,1,16648755
0,22.1,Renal impairment,2,16648771
1,22.1,Tubulointerstitial nephritis,2,16648771
0,22.0,Drug resistance,6,16648784
0,22.0,Anaemia,2,16648785
1,22.0,Myelodysplastic syndrome,6,16648785
0,22.0,Impaired healing,1,16648787
0,22.0,Vomiting,6,16648796
1,22.0,Nausea,6,16648796
2,22.0,Anxiety,6,16648796
3,22.0,Pneumonitis,6,16648796
4,22.0,Abdominal pain upper,6,16648796
0,22.0,Drug resistance,6,16648809
0,22.0,Drug resistance,6,16648811
0,22.1,Neutropenia,2,16648875
1,22.1,Toothache,2,16648875
2,22.1,Neutropenia,1,16648875
3,22.1,Glomerular filtration rate decreased,3,16648875
4,22.1,Nausea,3,16648875
5,22.1,Thrombocytopenia,3,16648875
6,22.1,Musculoskeletal chest pain,1,16648875
7,22.1,Hyperglycaemia,2,16648875
8,22.1,Leukopenia,2,16648875
9,22.1,Haemorrhoids,6,16648875
10,22.1,Blood pressure systolic increased,2,16648875
11,22.1,Neutropenia,1,16648875
12,22.1,Renal impairment,3,16648875
13,22.1,Fall,1,16648875
0,22.1,Mucosal dryness,2,16648886
1,22.1,Amylase decreased,6,16648886
2,22.1,Febrile neutropenia,1,16648886
3,22.1,Rhinovirus infection,6,16648886
4,22.1,Clostridium test positive,6,16648886
5,22.1,Diarrhoea,3,16648886
6,22.1,Rhinorrhoea,6,16648886
7,22.1,Pyrexia,1,16648886
8,22.1,Cough,6,16648886
9,22.1,Vomiting,2,16648886
10,22.1,Gastroenteritis norovirus,1,16648886
11,22.1,Pallor,2,16648886
12,22.1,Anaemia,6,16648886
13,22.1,Platelet count decreased,2,16648886
14,22.1,Pyrexia,1,16648886
15,22.1,Abdominal pain,2,16648886
16,22.1,White blood cell count decreased,2,16648886
17,22.1,Constipation,6,16648886
18,22.1,Lipase decreased,6,16648886
19,22.1,Product use in unapproved indication,6,16648886
0,22.0,Pneumonia,6,16648905
1,22.0,Mucosal disorder,6,16648905
2,22.0,Aphonia,6,16648905
3,22.0,Pyrexia,6,16648905
0,22.1,Supraventricular tachycardia,6,16648913
1,22.1,Product dose omission,6,16648913
2,22.1,Off label use,6,16648913
0,22.0,Oxygen saturation decreased,6,16648960
1,22.0,Bacterial infection,6,16648960
0,22.1,Pulmonary embolism,4,16648964
1,22.1,Pneumothorax,1,16648964
0,22.0,Pyrexia,6,16648965
0,22.0,Ageusia,1,16648969
1,22.0,Weight decreased,1,16648969
2,22.0,Death,5,16648969
0,22.0,Death,5,16648991
0,22.0,Drug resistance,6,16648998
0,22.0,Hypertriglyceridaemia,3,16649013
1,22.0,Diabetes mellitus,3,16649013
2,22.0,Myocardial infarction,1,16649013
0,22.0,Non-small cell lung cancer,6,16649061
1,22.0,Malignant neoplasm progression,6,16649061
2,22.0,Dermatomyositis,6,16649061
0,22.0,Urinary tract infection,3,16649080
1,22.0,Drug interaction,6,16649080
2,22.0,Arthralgia,3,16649080
3,22.0,Subdural haematoma,6,16649080
0,22.0,Radiation pneumonitis,5,16649081
1,22.0,Interstitial lung disease,5,16649081
2,22.0,Pneumothorax,5,16649081
0,22.0,Neuralgia,6,16649085
0,22.0,Nausea,3,16649102
1,22.0,Proteinuria,3,16649102
2,22.0,Polyneuropathy,3,16649102
3,22.0,Fatigue,3,16649102
4,22.0,Tremor,3,16649102
5,22.0,Device related sepsis,3,16649102
6,22.0,Decreased appetite,3,16649102
7,22.0,Weight decreased,1,16649102
8,22.0,Chills,3,16649102
9,22.0,Drug hypersensitivity,1,16649102
10,22.0,Bronchitis,3,16649102
11,22.0,Dry mouth,3,16649102
0,22.0,Hair texture abnormal,3,16649119
1,22.0,Hair colour changes,3,16649119
2,22.0,Madarosis,3,16649119
3,22.0,Hair disorder,3,16649119
4,22.0,Depression,6,16649119
5,22.0,Alopecia,3,16649119
0,22.0,Hair texture abnormal,3,16649121
1,22.0,Hair colour changes,3,16649121
2,22.0,Alopecia,3,16649121
3,22.0,Madarosis,3,16649121
4,22.0,Hair disorder,3,16649121
0,22.1,Madarosis,3,16649127
1,22.1,Hair colour changes,3,16649127
2,22.1,Alopecia,3,16649127
3,22.1,Hair texture abnormal,3,16649127
4,22.1,Hair disorder,3,16649127
0,22.0,White blood cell count decreased,6,16649138
0,22.0,Diarrhoea,1,16649209
0,22.0,Fall,3,16649221
1,22.0,Off label use,6,16649221
2,22.0,Head injury,3,16649221
3,22.0,Non-Hodgkin^s lymphoma,3,16649221
4,22.0,Non-small cell lung cancer recurrent,3,16649221
0,22.0,Lymphoedema,2,16649233
0,22.0,Death,5,16649242
1,22.0,Therapeutic response decreased,6,16649242
0,22.0,Urosepsis,6,16649318
1,22.0,Febrile neutropenia,6,16649318
0,22.0,Acute kidney injury,5,16649497
1,22.0,Malignant neoplasm progression,6,16649497
0,22.0,Drug ineffective,6,16649529
0,22.0,Dyspepsia,3,16649547
1,22.0,Nausea,1,16649547
2,22.0,Back pain,6,16649547
3,22.0,Mouth ulceration,6,16649547
4,22.0,Pleural effusion,6,16649547
5,22.0,Vomiting,6,16649547
6,22.0,Weight decreased,6,16649547
7,22.0,Decreased appetite,2,16649547
8,22.0,Diarrhoea,3,16649547
9,22.0,Asthenia,6,16649547
10,22.0,Hypotension,6,16649547
11,22.0,Tongue ulceration,3,16649547
0,22.0,Clostridium difficile colitis,1,16649550
0,22.0,Dyspnoea,6,16649578
0,22.0,Vomiting,3,16649659
1,22.0,Acute kidney injury,3,16649659
2,22.0,Nausea,3,16649659
0,22.0,Atrial fibrillation,6,16649726
1,22.0,Dyspnoea,2,16649726
2,22.0,Urinary retention,6,16649726
3,22.0,Chronic obstructive pulmonary disease,2,16649726
4,22.0,Condition aggravated,2,16649726
5,22.0,Drug interaction,2,16649726
0,22.0,Joint swelling,1,16649738
1,22.0,Peripheral swelling,1,16649738
2,22.0,Tremor,6,16649738
0,22.0,Diabetes mellitus,6,16649791
1,22.0,Ketoacidosis,1,16649791
2,22.0,Glycosylated haemoglobin increased,1,16649791
3,22.0,Blood glucose increased,1,16649791
0,22.0,Neoplasm malignant,6,16649831
1,22.0,Chest pain,6,16649831
0,22.0,Atrial fibrillation,2,16649899
1,22.0,Influenza,1,16649899
0,22.1,Walking aid user,6,16649928
1,22.1,Wound,6,16649928
2,22.1,Unresponsive to stimuli,6,16649928
3,22.1,Fall,6,16649928
4,22.1,Fall,1,16649928
5,22.1,Hypotension,2,16649928
0,22.0,Lichenification,2,16649965
1,22.0,Anaemia,6,16649965
2,22.0,Neutropenia,6,16649965
3,22.0,Palmar-plantar erythrodysaesthesia syndrome,2,16649965
0,22.0,Bacterial colitis,2,16649997
1,22.0,Oral herpes,2,16649997
0,22.1,Cardiac failure,1,16650008
1,22.1,Arrhythmia supraventricular,3,16650008
0,22.0,Incorrect dose administered,6,16650109
1,22.0,White blood cell count abnormal,6,16650109
0,22.0,Hypothyroidism,1,16650113
0,22.0,Cellulitis,6,16650115
1,22.0,Oedema peripheral,3,16650115
2,22.0,Movement disorder,6,16650115
3,22.0,Scleroderma,6,16650115
0,22.0,Hyperglycaemia,2,16650137
0,22.0,Lung disorder,1,16650158
0,22.0,Tremor,6,16650164
1,22.0,Seizure,6,16650164
2,22.0,Hypocalcaemia,6,16650164
0,22.1,Pyrexia,3,16650178
1,22.1,Pneumonia,3,16650178
2,22.1,Malignant neoplasm progression,6,16650178
3,22.1,C-reactive protein increased,6,16650178
0,22.0,Drug interaction,6,16650281
1,22.0,Drug level decreased,6,16650281
0,22.0,Brain injury,6,16650289
0,22.0,Acute respiratory distress syndrome,2,16650365
0,22.1,Nausea,3,16650368
0,22.0,Cardiac failure acute,6,16650397
0,22.0,Febrile neutropenia,1,16650437
1,22.0,Anaemia,1,16650437
2,22.0,Pancytopenia,3,16650437
3,22.0,Pyrexia,3,16650437
4,22.0,Fatigue,3,16650437
5,22.0,Lymphocyte count decreased,1,16650437
6,22.0,Platelet count decreased,1,16650437
0,22.0,Neurotoxicity,6,16650464
0,22.0,Anaemia,3,16650467
1,22.0,Thrombocytopenia,3,16650467
0,22.0,Bone marrow failure,2,16650490
0,22.0,Stress,6,16650496
1,22.0,Bronchitis,3,16650496
2,22.0,Abdominal lymphadenopathy,6,16650496
3,22.0,Platelet count decreased,3,16650496
4,22.0,Inappropriate schedule of product administration,6,16650496
5,22.0,Product dose omission,6,16650496
6,22.0,Kidney infection,6,16650496
7,22.0,Neuropathy peripheral,6,16650496
8,22.0,Chest pain,6,16650496
9,22.0,Hypertension,6,16650496
10,22.0,Fatigue,6,16650496
0,22.0,Death,5,16650574
0,22.0,Rash,6,16650585
1,22.0,Blood glucose increased,6,16650585
2,22.0,Vomiting,6,16650585
0,22.0,Respiratory failure,5,16650595
0,22.1,Rash pruritic,1,16650596
1,22.1,Rash,1,16650596
2,22.1,Chills,1,16650596
3,22.1,Erythema,1,16650596
4,22.1,Abdominal distension,1,16650596
0,22.0,Deep vein thrombosis,6,16650612
1,22.0,Nodule,6,16650612
2,22.0,Dyspepsia,6,16650612
3,22.0,Headache,6,16650612
4,22.0,Vena cava thrombosis,6,16650612
0,22.0,Malignant neoplasm progression,5,16650620
1,22.0,Asthma,6,16650620
2,22.0,Nasopharyngitis,6,16650620
3,22.0,Rash,6,16650620
4,22.0,Vomiting,6,16650620
5,22.0,Pruritus,6,16650620
6,22.0,Lymphadenopathy,5,16650620
7,22.0,Pyrexia,6,16650620
8,22.0,Disseminated intravascular coagulation,6,16650620
9,22.0,Gait disturbance,6,16650620
10,22.0,General physical health deterioration,6,16650620
11,22.0,Generalised oedema,6,16650620
12,22.0,Pyrexia,1,16650620
13,22.0,Staphylococcal sepsis,6,16650620
14,22.0,Gastrooesophageal reflux disease,6,16650620
15,22.0,Feeding disorder,6,16650620
16,22.0,Cough,1,16650620
17,22.0,Non-small cell lung cancer recurrent,5,16650620
18,22.0,Pneumonia moraxella,6,16650620
19,22.0,Oral candidiasis,6,16650620
20,22.0,Decreased appetite,6,16650620
21,22.0,Stomatitis,6,16650620
0,22.0,Renal disorder,5,16650636
0,22.0,Death,5,16650648
0,22.0,Dehydration,6,16650669
1,22.0,Hepatic infection,6,16650669
2,22.0,Hospitalisation,6,16650669
0,22.0,Blast cell crisis,2,16650682
0,22.0,Myelodysplastic syndrome,3,16650686
1,22.0,Second primary malignancy,3,16650686
0,22.1,Guillain-Barre syndrome,2,16650721
1,22.1,Malaise,6,16650721
2,22.1,Musculoskeletal stiffness,6,16650721
3,22.1,Neutrophil count decreased,6,16650721
4,22.1,Ascites,1,16650721
5,22.1,Pleural effusion,1,16650721
6,22.1,Pericardial effusion,1,16650721
7,22.1,White blood cell count decreased,6,16650721
0,22.0,Pain,6,16650754
1,22.0,Fall,6,16650754
2,22.0,Inappropriate schedule of product administration,6,16650754
3,22.0,Peripheral swelling,6,16650754
0,22.1,Tumour pain,3,16650763
1,22.1,Chronic respiratory failure,3,16650763
0,22.0,Septic shock,5,16650772
1,22.0,Fournier^s gangrene,5,16650772
0,22.1,Hyponatraemia,1,16650809
1,22.1,Inappropriate antidiuretic hormone secretion,1,16650809
2,22.1,Hyperthyroidism,3,16650809
0,22.0,Interstitial lung disease,2,16650813
0,22.0,Bone marrow failure,1,16650898
1,22.0,Agranulocytosis,1,16650898
0,22.0,Dizziness,2,16650939
1,22.0,Off label use,6,16650939
2,22.0,Back pain,2,16650939
0,22.0,Bone marrow failure,1,16650958
0,22.0,Injection site bruising,6,16650973
1,22.0,Gait disturbance,6,16650973
2,22.0,Pain in extremity,6,16650973
3,22.0,Injection site pain,6,16650973
0,22.1,Renal impairment,1,16650981
1,22.1,Renal impairment,1,16650981
2,22.1,Anaemia,1,16650981
0,22.0,Fall,6,16650993
1,22.0,Hip fracture,6,16650993
0,22.0,Metastases to lung,3,16651008
1,22.0,Hormone level abnormal,3,16651008
2,22.0,Metastases to bone,3,16651008
3,22.0,Metastases to ovary,6,16651008
4,22.0,Metastases to pelvis,6,16651008
5,22.0,Malignant neoplasm progression,6,16651008
0,22.0,Osteoma cutis,6,16651020
0,22.0,Escherichia infection,1,16651082
1,22.0,Bladder perforation,1,16651082
2,22.0,General physical health deterioration,1,16651082
3,22.0,Superinfection,1,16651082
4,22.0,Bladder necrosis,1,16651082
5,22.0,Urinary bladder abscess,1,16651082
0,22.0,Adverse event,6,16651084
0,22.0,Stomatitis,3,16651085
1,22.0,Rash,1,16651085
2,22.0,Blood alkaline phosphatase increased,1,16651085
3,22.0,Rash,3,16651085
4,22.0,Alanine aminotransferase increased,1,16651085
0,22.0,Acute kidney injury,6,16651090
0,22.0,Anaemia,6,16651124
1,22.0,Thrombocytopenia,6,16651124
2,22.0,Visual acuity reduced,6,16651124
3,22.0,"Hallucination, visual",6,16651124
4,22.0,Fatigue,6,16651124
0,22.1,Haematuria,3,16651147
1,22.1,Malignant neoplasm progression,5,16651147
2,22.1,Anaemia,6,16651147
3,22.1,Urinary bladder haemorrhage,6,16651147
0,22.0,Erosive oesophagitis,6,16651148
1,22.0,Gastritis erosive,6,16651148
2,22.0,Drug interaction,6,16651148
3,22.0,Therapeutic product effect decreased,6,16651148
0,22.1,Type 2 diabetes mellitus,3,16651226
1,22.1,Hyperglycaemia,4,16651226
2,22.1,Diabetes mellitus,3,16651226
3,22.1,Diabetic ketoacidosis,4,16651226
0,22.0,Gastroenteritis,1,16651265
0,22.1,Ventricular hypokinesia,6,16651327
1,22.1,Intentional product use issue,6,16651327
2,22.1,Atrial thrombosis,6,16651327
3,22.1,Atrial fibrillation,6,16651327
4,22.1,Off label use,6,16651327
0,22.0,Dehydration,1,16651336
0,22.0,Erythema,1,16651380
1,22.0,Dyspnoea,1,16651380
2,22.0,Hypersensitivity,1,16651380
3,22.0,Anxiety,1,16651380
4,22.0,Rash,1,16651380
5,22.0,Blood pressure increased,1,16651380
6,22.0,Abdominal pain,1,16651380
7,22.0,Chest pain,1,16651380
8,22.0,Tachycardia,1,16651380
0,22.0,Death,5,16651385
0,22.0,Death,5,16651406
0,22.0,Acute myeloid leukaemia,3,16651508
0,22.0,Product use in unapproved indication,6,16651520
1,22.0,Dizziness,6,16651520
0,22.0,Disease progression,,16651521
